Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 822 citations, 2015 year and closed oa status.
822
Citations
2015
Year
closed
OA Status